The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) securities during ...

Roman DBDR Acquisition Corp. II (“Roman DBDR” or the “Company”) (Nasdaq: DRDB) today announced the appointment of Hunter Gary ...

First approved ctDNA MRD-guided therapy reinforcing Genentech’s commitment to innovation and practice-changing precision medicineNew treatment approach enables healthcare professionals to tailor ...

IRB Approval Secured for PF614-MPAR-102 Part 3 ~~ Clinical Peer-Reviewed Data Published for First Overdose Protected Opioid PF614-MPAR®; Patent Estate Expanded ~~ Company Launches Formal Review of ...

WHEAT RIDGE, CO / ACCESS Newswire / May 15, 2026 / Lifeloc Technologies, Inc. (OTCID:LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has ...

By combining novel measures of brain function with a brain-penetrant dual GLP-1/GIP agonist program, NeuraLight and Kariya Pharmaceuticals aim to tackle one of neurodegeneration's central challenges: ...

Designation recognizes the product’s potential to address a critical unmet need in bladder cancer prognosis PALO ALTO, Calif.--(BUSINESS WIRE)--Valar Labs, an AI precision oncology company developing ...

TAMPA, FL / ACCESS Newswire / May 15, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today ...

Disciplined Execution Drives 47% Reduction in R&D Spend While Advancing Multiple Clinical Programs, Launching Multi-Agentic ...

BFA Law is investigating whether Wix committed securities fraud relating to its representations about demand for the company’s AI-powered web design tools, AI competition, and its ability to deliver ...

Company to attend Jefferies, Oppenheimer, and Cantor investor conferences focused on the biopharma sectorPLANO, Texas--(BUSINESS WIRE)--#Biotech--Secretome Therapeutics, a clinical-stage biotechnology ...

VANCOUVER, BC / ACCESS Newswire / May 15, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has advanced ...